Merck's Keytruda meets main goal in lung cancer trial, shares jump

Merck says a key test of Keytruda met the main goal of helping previously untreated lung cancer patients live longer.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>